✦ LIBER ✦

The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

✍ Scribed by E. A. Werber; J. M. Rabey

Book ID: 106208306
Publisher: Springer
Year: 2001
Tongue: English
Weight: 91 KB
Volume: 108
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020100008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of rivastigmine on tremor in pati

Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia

✍ Tanya Y. Gurevich; Herzel Shabtai; Amos D. Korczyn; Ely S. Simon; Nir Giladi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## Abstract The purpose of this study was to assess whether rivastigmine, a cholinergic agent, affects tremor features when given to improve cognition in demented Parkinson's disease (PD) patients. Demented PD patients (n = 26; Mini‐Mental State Examination score, 13–25; age, 75.2 ± 4.9 yr) were gi

A review of studies describing the use o

A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia

✍ I. D. Maidment; C. Fox; M. Boustani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Cardio-vascular safety of acetyl choline

Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability

✍ Daniel Kinnair; Chip Machili; Richard Prettyman; Erik Van Diepen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Effects of levodopa and COMT inhibitors

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

✍ Paolo Lamberti; Stefano Zoccolella; Giovanni Iliceto; Elio Armenise; Angela Frad 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Abstract Homocysteine (Hcy) is a risk factor for vascular diseases, cognitive impairment, and dementia. Elevated plasma concentrations of Hcy have been found recently in Parkinson's disease (PD) patients treated with levodopa, suggesting that levodopa is a cause of hyperhomocysteinemia (HHcy). T

The effect of memantine on sleep behavio

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia

✍ Victoria Larsson; Dag Aarsland; Clive Ballard; Lennart Minthon; Elisabet Londos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

## Abstract ## Objective Two common and characteristic sleep disturbances have been described in dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD); excessive daytime sleepiness and REM sleep behaviour disorder (RBD). This study is an analysis of a secondary outcome measure of

Combined effect of age and severity on t

Combined effect of age and severity on the risk of dementia in Parkinson's disease

✍ Gilberto Levy; Nicole Schupf; Ming-Xin Tang; Lucien J. Cote; Elan D. Louis; Hele 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views